These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3091928)

  • 41. Physiological basis for an animal model of the renal Fanconi syndrome: use of succinylacetone in the rat.
    Wyss PA; Boynton SB; Chu J; Spencer RF; Roth KS
    Clin Sci (Lond); 1992 Jul; 83(1):81-7. PubMed ID: 1325326
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Tyrosinaemia type I: orthotopic liver transplantation as the only definitive answer to a metabolic as well as an oncological problem.
    van Spronsen FJ; Berger R; Smit GP; de Klerk JB; Duran M; Bijleveld CM; van Faassen H; Slooff MJ; Heymans HS
    J Inherit Metab Dis; 1989; 12 Suppl 2():339-42. PubMed ID: 2556611
    [No Abstract]   [Full Text] [Related]  

  • 43. The antenatal diagnosis and aid to the management of hereditary tyrosinaemia by use of a specific and sensitive GC-MS assay for succinylacetone.
    Pettit BR; MacKenzie F; King GS; Leonard JV
    J Inherit Metab Dis; 1984; 7 Suppl 2():135-6. PubMed ID: 6434868
    [No Abstract]   [Full Text] [Related]  

  • 44. Hereditary tyrosinemia. Formation of succinylacetone-amino acid adducts.
    Manabe S; Sassa S; Kappas A
    J Exp Med; 1985 Sep; 162(3):1060-74. PubMed ID: 3928801
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Phosphate metabolism in renal stone formers. (II): Relation to renal tubular functions and calcium metabolism.
    Wikström B; Backman U; Danielson BG; Fellström B; Johansson G; Ljunghall S; Wide L
    Scand J Urol Nephrol Suppl; 1981; 61():II:1-26. PubMed ID: 6274002
    [TBL] [Abstract][Full Text] [Related]  

  • 46. On the enzymic defects in hereditary tyrosinemia.
    Lindblad B; Lindstedt S; Steen G
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4641-5. PubMed ID: 270706
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Surgical and metabolic aspects of liver transplantation for tyrosinemia].
    Bruneau N; St-Vil D; Luks FI; LaBerge JM; Bensoussan AL; Blanchard H
    Ann Chir; 1993; 47(9):803-9. PubMed ID: 8141543
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Hereditary tyrosinemia and the heme biosynthetic pathway. Profound inhibition of delta-aminolevulinic acid dehydratase activity by succinylacetone.
    Sassa S; Kappas A
    J Clin Invest; 1983 Mar; 71(3):625-34. PubMed ID: 6826727
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I.
    Grompe M; Lindstedt S; al-Dhalimy M; Kennaway NG; Papaconstantinou J; Torres-Ramos CA; Ou CN; Finegold M
    Nat Genet; 1995 Aug; 10(4):453-60. PubMed ID: 7545495
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Liver transplantation in tyrosinaemia type 1: the dilemma of timing the operation.
    Salt A; Barnes ND; Rolles K; Calne RY; Clayton PT; Leonard JV
    Acta Paediatr; 1992 May; 81(5):449-52. PubMed ID: 1323361
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Resolution of the clinical features of tyrosinemia following orthotopic liver transplantation for hepatoma.
    Van Thiel DH; Gartner LM; Thorp FK; Newman SL; Lindahl JA; Stoner E; New MI; Starzl TE
    J Hepatol; 1986; 3(1):42-8. PubMed ID: 3018074
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tyrosinemia: a report of three cases from India.
    Shah I
    Indian J Gastroenterol; 2013 Mar; 32(2):123-6. PubMed ID: 23408258
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Renal dose dopamine in open heart surgery. Does it protect renal tubular function?
    Yavuz S; Ayabakan N; Dilek K; Ozdemir A
    J Cardiovasc Surg (Torino); 2002 Feb; 43(1):25-30. PubMed ID: 11803323
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tandem mass spectrometric determination of succinylacetone in dried blood spots enables presymptomatic detection in a case of hepatorenal tyrosinaemia.
    Weigel JF; Janzen N; Pfäffle RW; Thiery J; Kiess W; Ceglarek U
    J Inherit Metab Dis; 2007 Aug; 30(4):610. PubMed ID: 17694358
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical features and diagnostic approach in type I tyrosinaemia in an infant with cytomegaly virus infection and bacterial sepsis.
    Wabitsch M; Pohlandt F; Leupold D; Berger R; Mönch E; Heinze E; Teller W
    Eur J Pediatr; 1993 Apr; 152(4):327-30. PubMed ID: 8387006
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [On some aspects of renal tubule physiopathology in childhood].
    Bottone E; Macchia PA; Baldini G; Bani E
    Minerva Pediatr; 1973 Jul; 25(25):1073-118. PubMed ID: 4356737
    [No Abstract]   [Full Text] [Related]  

  • 57. Influence of albumin infusion on the urinary excretion of beta2-microglobulin in patients with proteinuria.
    Branten AJ; Wetzels JF
    Nephron; 1999; 81(3):329-33. PubMed ID: 10050089
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Evidence for liver disease preceding amino acid abnormalities in hereditary tyrosinemia.
    Hostetter MK; Levy HL; Winter HS; Knight GJ; Haddow JE
    N Engl J Med; 1983 May; 308(21):1265-7. PubMed ID: 6188953
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Hyperparathyroidism associated with distal tubular dysfunction but intact reabsorption of protein in the proximal tubules.
    Wibell L; Dahlberg PA; Karlsson A
    Acta Med Scand; 1979; 206(6):507-10. PubMed ID: 93849
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Early liver transplantation is indicated for tyrosinemia type I.
    Freese DK; Tuchman M; Schwarzenberg SJ; Sharp HL; Rank JM; Bloomer JR; Ascher NL; Payne WD
    J Pediatr Gastroenterol Nutr; 1991 Jul; 13(1):10-5. PubMed ID: 1919940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.